Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study
Metastatic uveal melanoma is a rare disease with a poor prognosis. Usual treatments have not proven effective. Tebentafusp, a bispecific protein targeting melanoma cells and T lymphocytes, is the first approved treatment with a proven survival benefit in a randomized clinical. Our purpose was to eva...
Saved in:
| Main Authors: | Lucille Vitek, Thomas Goronflot, Caroline Dutriaux, Antoine Deleuze, Yannick Le Corre, Anne-Bénédicte Duval-Modeste, Cécile Fresnard, Géraldine Jeudy, Anouck Lamoureux, Caroline Gaudy-Marqueste, Delphine Legoupil, Barouyr Baroudjian, Jean-Matthieu L'Orphelin, Lucie Peuvrel, Amir Khammari, Laurent Mortier, Gaëlle Quereux |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Journals Sweden
2024-12-01
|
| Series: | Acta Dermato-Venereologica |
| Subjects: | |
| Online Access: | https://medicaljournalssweden.se/actadv/article/view/41297 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis
by: Yating Dian, et al.
Published: (2024-12-01) -
Monitoring soluble cMET and ctDNA in metastatic uveal melanoma patients to track early disease progression on immunotherapies
by: Devayani Machiraju, et al.
Published: (2025-07-01) -
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
by: Manuel Rodrigues, et al.
Published: (2024-10-01) -
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
by: Jessica C Hassel, et al.
Published: (2024-06-01) -
Fundus hypopigmentation and choroidal thinning associated with tebentafusp therapy: report of a case and literature review
by: Jørgen Krohn, et al.
Published: (2025-08-01)